
Veterinary Apothecary (Vol 2; No 1)
Your dose of veterinary pharmacology news from dvm360®.
Subscribe to the Veterinary Apothecary newsletter on
Federal Approvals
Atinvicitinib tablets (Numelvi; Merck Animal Health) will control pruritus associated with allergic dermatitis in canines.
In September 2025, the FDA issued a conditional approval for another drug indicated to prevent and treat New World screwworm (NWS) larval infestations in cattle.
This is the first USDA-licensed ½ mL oral Bordetella bronchiseptica vaccination for dogs.
Research and Development
A study reveals promising results for niclosamide stearate in treating canine osteosarcoma, suggesting potential for further clinical trials and improved survival rates.
Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary Medicine.
The challenges of methicillin-resistant infections in pets and what the current research says were presented at the 2026 Veterinary Meeting & Expo.
Commentary
Christina Gentry, DVM, DACVD, discusses dermatologic signs that a patient is in need of immediate attention, including adverse reactions to medications.
Dottie Brown, DVM, MS, DACVS, discussed how Mars Veterinary Health is using medical records to address a One Health issue, in a dvm360 interview.
Acupuncture can address aspects of homeostatic balance that drugs alone don’t reach, explains Bonnie D. Wright, DVM, DACVAA, CVMA, CVPP, CCRT, CCRP.
Other Pharmaceutical News
Veterinarians gain a new FDA-approved generic dewormer (Defendazole; Norbrook) for the treatment and control of various worms in cattle and goats.
Vetnique Labs showcased 2 new supplements and more at the 2026 Veterinary Meeting & Expo.
Jane Sykes, BVSc, PhD, MPH, MBA, FNAP, covers the biggest shift in recommendations, how to talk to owners about vaccine safety, when to test, and how to handle suspected cases safely in the clinic.
For more news and insights on veterinary pharmacy, visit dvm360’s online









